Free equity investment tool of Japanese companies

HOME >
Company List >
Nissui Pharmaceutical (Annual ): Financial Outline Report

Financial Outline Report: Annual; First quarter; Second quarter; Third quarter

Sponsored Link

Related Company: DAINICHISEIKA COLOR & CHEMICALS MFG.; 和光純薬工業; 日本曹達; SANKO GOSEI; MUTO SEIKO CO.; SATO PHARMACEUTICAL; NITTO FC; KUREHA; ZEON; C.Uyemura; 参天製薬; POLA ORBIS HOLDINGS; FUJIKURA KASEI; ZERIA PHARMACEUTICAL; DAISO

EDIUNET Related Ranking: EDIUNET; EDIUNET Credit Rating; EDIUNET Industry Avg; EDIUNET Prefectures; Yuho! Industry

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

RSS

Company RSS

Daily RSS

Sponsored Link

Recently Download Chart: NITCHITSU　

PIONEER etc.

SANKEI CHEMICAL

日本セラミック

日本セラミック

Financial Outline Report: Nissui Pharmaceutical (Annual )

It is a free Financial Outline Report which can grasp intuitively a financial statement summary , a corporate value, credit rating, etc. by various charts.Two or more companies can be compared and various charts can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Summary: Nissui Pharmaceutical (Annual )

Credit Rating (Bankruptcy Risk) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2011-03-31	AA	Credit is very high, slightly affected by biz environs.	¥ 13 B 6.61%	¥ 2 B 19.93%	¥ 1 B 38.18%

Financial Timeline

Date	- (First quarter )	- (Second quarter )	2010-12-31 (Third quarter )	2011-03-31 (Annual )
Credit Rating	-	-	AA	AA
Total Assets	-	-	¥ 28 B	¥ 27 B
Net Assets	-	-	¥ 26 B	¥ 24 B

Net income has increased 3 consecutive terms. The performance is good.

Net Assets have increased 3consecutive terms. The fiscal base is getting better.

Cash(¥ 3 B) is more than the total liabilities(¥ 3 B). It is a very steady fiscal base!

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-03-31	B	Credit is not enough, easily undermined by biz environs.	¥ 13 B -1.49%	¥ 3 B 10.98%	¥ 2 B 38.14%

Date	2012-12-31 (Third quarter )	2013-03-31 (Annual )	2013-06-30 (First quarter )	2013-09-30 (Second quarter )
Credit Rating	BB	B	BB	AA
Total Assets	¥ 28 B	¥ 30 B	¥ 30 B	¥ 31 B
Net Assets	¥ 26 B	¥ 27 B	¥ 27 B	¥ 28 B

Financial Chart Download

Financial Timeline Chart

Financial Statement Details

Indicator Comparison Chart

Financial Indicator Details

Profitability	2009-03-31	2010-03-31	2011-03-31
Net profit margin (Industry Average)	3.12% (1.53%)	7.38% (-1.67%)	9.57% (3.05%)
C/F margin (Industry Average)	7.25% (7.04%)	17.34% (6.35%)	12.24% (8.25%)
ROA (Industry Average)	1.72% (2.07%)	3.38% (0.06%)	4.59% (2.71%)
ROE (Industry Average)	1.96% (2.96%)	3.87% (4.68%)	5.21% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31
Equity growth (Industry Average)	- (2.61%)	4.10% (-0.40%)	2.67% (8.16%)
Sales growth (Industry Average)	- (-)	-13.42% (1.07%)	6.61% (2.24%)
Net profit growth (Industry Average)	- (63.25%)	104.90% (3.89%)	38.18% (90.38%)
Operating C/F growth (Industry Average)	- (35.09%)	106.93% (-6.09%)	-24.69% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31
Capital adequacy (Industry Average)	87.80% (55.00%)	87.49% (53.59%)	88.13% (56.30%)
Liquidity ratio (Industry Average)	585.29% (237.55%)	516.63% (239.89%)	589.50% (236.21%)
C/F ratio current liabilities (Industry Average)	222.49% (434.79%)	117.86% (929.73%)	149.37% (573.30%)
Quick ratio (Industry Average)	235.99% (156.17%)	218.76% (160.84%)	269.12% (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31
Receivables turnover (Industry Average)	88.33day (93.96day)	91.11day (97.92day)	82.84day (98.27day)
Inventory turnover (Industry Average)	67.42day (52.64day)	74.11day (56.59day)	65.84day (58.68day)
Payable turnover (Industry Average)	34.03day (49.52day)	35.15day (52.10day)	30.72day (51.12day)
Working capita turnover (Industry Average)	121.71day (97.08day)	130.07day (102.41day)	117.95day (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31
Market Value growth (Industry Average)	- (1.49%)	-4.09% (-3.85%)	0.42% (21.16%)
Dividend Yield (Industry Average)	2.58% (2.17%)	2.83% (2.45%)	3.23% (2.07%)
PER (Industry Average)	36.73% (16.22%)	17.19% (29.19%)	12.49% (16.58%)
PBR (Industry Average)	0.72% (1.04%)	0.66% (0.95%)	0.65% (1.08%)
PCFR (Industry Average)	15.80% (-2.43%)	7.32% (9.50%)	9.77% (7.56%)
PSR (Industry Average)	1.14% (1.10%)	1.27% (0.90%)	1.19% (1.01%)

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	3.61% (-27.66%)	8.72% (-4.34%)	13.26% (-5.37%)	12.06% (-10.69%)	16.91% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	14.20% (-0.81%)	13.32% (-39.63%)
ROA (Industry Average)	1.73% (0.52%)	4.00% (0.92%)	5.86% (1.42%)	5.67% (-0.27%)	7.27% (1.53%)
ROE (Industry Average)	1.97% (-0.84%)	4.65% (-0.46%)	6.63% (1.81%)	6.36% (3.42%)	8.06% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	4.96% (3.64%)	4.20% (3.03%)	4.26% (0.04%)	8.90% (3.91%)
Sales growth (Industry Average)	- (-)	2.19% (-3.48%)	-2.25% (6.70%)	9.95% (0.75%)	-1.49% (-1.74%)
Net profit growth (Industry Average)	- (-)	146.80% (166.48%)	48.53% (43.48%)	- (-47.04%)	38.14% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	-7.58% (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	87.89% (56.79%)	86.01% (57.65%)	88.41% (57.17%)	89.28% (55.93%)	90.23% (57.57%)
Liquidity ratio (Industry Average)	576.56% (337.22%)	445.22% (276.75%)	583.76% (266.94%)	648.36% (314.47%)	698.53% (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	134.63% (76.77%)	143.34% (31.87%)
Quick ratio (Industry Average)	219.13% (167.28%)	188.04% (183.78%)	248.75% (174.83%)	210.44% (228.06%)	209.72% (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	93.72day (87.55day)	91.11day (98.39day)	88.45day (95.88day)	83.42day (98.58day)	85.32day (67.18day)
Inventory turnover (Industry Average)	77.74day (50.17day)	74.11day (48.43day)	67.25day (47.43day)	67.85day (50.67day)	75.63day (38.21day)
Payable turnover (Industry Average)	32.33day (45.70day)	35.15day (51.63day)	33.34day (51.13day)	31.27day (53.57day)	31.54day (34.24day)
Working capita turnover (Industry Average)	139.12day (92.02day)	130.07day (95.19day)	122.36day (92.19day)	120.00day (95.69day)	129.40day (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	-4.09% (34.46%)	0.42% (3.11%)	7.80% (-3.30%)	34.87% (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	3.39% (0.16%)	2.89% (0.15%)
PER (Industry Average)	37.46% (34.12%)	14.55% (27.80%)	9.84% (13.58%)	10.60% (22.26%)	10.35% (26.42%)
PBR (Industry Average)	0.74% (0.97%)	0.67% (1.21%)	0.65% (1.17%)	0.67% (1.08%)	0.83% (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	9.00% (0.08%)	13.14% (4.97%)
PSR (Industry Average)	1.35% (3.42%)	1.27% (4.34%)	1.30% (3.67%)	1.27% (4.37%)	1.75% (10.14%)

Corporate value chart

Enterprise Value	2009-03-31	2010-03-31	2011-03-31
Market Value	¥ 16 B (1)	¥ 15 B (1)	¥ 15 B (1)
Net Value	¥ 22 B (0.72)	¥ 23 B (0.67)	¥ 24 B (0.65)
Returns Value	¥ 9 B (1.82)	¥ 13 B (1.19)	¥ 16 B (0.94)
Dividend Value	¥ 8 B (1.92)	¥ 6 B (2.45)	¥ 6 B (2.32)
Enterprise Value	¥ 14 B (1.14)	¥ 13 B (1.18)	¥ 12 B (1.29)

Enterprise Value	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value	¥ 16 B (1)	¥ 15 B (1)	¥ 15 B (1)	¥ 17 B (1)	¥ 23 B (1)
Net Value	¥ 22 B (0.74)	¥ 23 B (0.68)	¥ 24 B (0.65)	¥ 25 B (0.67)	¥ 27 B (0.84)
Returns Value	¥ 8 B (1.85)	¥ 22 B (0.71)	¥ 26 B (0.6)	¥ 19 B (0.87)	¥ 21 B (1.05)
Dividend Value	- (- )	- (- )	- (- )	¥ 7 B (2.41)	¥ 6 B (3.5)
Enterprise Value	¥ 14 B (1.12)	¥ 13 B (1.18)	¥ 13 B (1.22)	¥ 14 B (1.16)	¥ 20 B (1.11)

Related Information: Nissui Pharmaceutical (Annual )

Statement Type: Annual : Nissui Pharmaceutical; First quarter : Nissui Pharmaceutical; Second quarter : Nissui Pharmaceutical; Third quarter : Nissui Pharmaceutical

Analysis Menu: Outline : Nissui Pharmaceutical; Statement : Nissui Pharmaceutical; Rating : Nissui Pharmaceutical; Indicator : Nissui Pharmaceutical; Download : Nissui Pharmaceutical

Industry Comparison Ranking: Chemicals - EDIUNET Industry Rankings; Chemicals - EDIUNET Credit Rating; Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company: Tokyo - EDIUNET Prefectures; Tokyo台東区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals): 1/23 Chemicals (Milbon:AA→AAA); 1/17 Chemicals (Kawaguchi Chemica..; 1/15 Chemicals (HOKKO CHEMICAL IN..; 1/10 Chemicals (OSAKA ORGANIC CHE..; 1/9 Chemicals (SANKO GOSEI:A); 12/27 Chemicals (Niitaka:A); 12/18 Chemicals (KUMIAI CHEMICAL I..; 12/12 Chemicals (IHARA CHEMICAL IN..; 12/11 Chemicals (Konoshima Chemica..; 12/10 Chemicals (NATOCO:AA)

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

HOME >
Company List >
Nissui Pharmaceutical (Annual ): Financial Outline Report

EDIUNET Rating News

Screening Search

Member limited service

Company Search
- [close]
  
  [keyword]
  
  Company Search
  
  *It can search to each item of a type of industry, a stock market, the settlement-of-accounts moon, and a keyword.
  
  *Top 30 search results are displayed.
  
  [close]

Company Ranking

Free equity investment tool of Japanese companies

Financial Outline Report: Nissui Pharmaceutical (Annual )

Summary: Nissui Pharmaceutical (Annual )

Credit Rating (Bankruptcy Risk) Consolidated | Non-Consolidated

Financial Timeline

Credit Rating (Bankruptcy Risk) Consolidated | Non-Consolidated

Financial Timeline

Financial Chart Download

Financial Timeline Chart

Indicator Comparison Chart

Consolidated :Indicator Consolidated | Non-Consolidated

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Corporate value chart

Related Information: Nissui Pharmaceutical (Annual )

Related company's newest statement

Related Company

関連する株式投資情報

EDIUNET Caution